Biotron Limited (ASX:BIT) is a Sydney-based, publicly traded Australian biotechnology company currently in the clinical trial stage. They're pioneering a new approach using small molecules to potentially treat a range of serious viral diseases. This technology has the potential to be a game-changer in the fight against viruses.